Business Wire

Rocket Lab Successfully Launches First of Two Climate Science Satellites for NASA

The satellite was the first of two that will launch on Electron for NASA’s PREFIRE mission to detect heat loss over the Arctic and AntarcticaMAHIA, New Zealand--(BUSINESS WIRE)--Rocket Lab USA, Inc. (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a...

Bloom Energy Corporation Prices Upsized $350.0 Million Green Convertible Senior Notes Offering

SAN JOSE, Calif.--(BUSINESS WIRE)--Bloom Energy Corporation (NYSE:BE) today announced the pricing of its offering of $350.0 million aggregate principal amount of 3.00% green convertible senior notes due 2029 (the “notes”) in a private offering to persons reasonably believed to...

Innate Pharma Highlights Abstracts Selected for ASCO 2024 Annual Meeting

Top line results of TELLOMAK Phase 2 trial in mycosis fungoides confirming promising clinical activity of lacutamab Two posters on IPH6501, Innate’s second generation ANKET®, for the treatment of relapsed/refractory CD20-expressing B-cell Non-Hodgkin's Lymphoma AstraZeneca to present poster on updated results...

Scottish Sensor Technology Startup Novosound Targets Expansion in APAC

Novosound’s Ceilidh system, a wide area corrosion monitoring system for industrial groups seeking to improve efficiency and safety of assets, will be featured at the 20th World Conference for Non-Destructive Testing (WCNDT) in Incheon, South Korea between 27th-31st May CEO...

Kao Releases Progress Reports on its ESG Strategy—the Kirei Lifestyle Plan

Report on Implementation of New Biodiversity, Respect for Human Rights and DE&I Initiatives, Improved Traceability for Palm Oil Procurement, and Impact of ESG Activities on Financial Results and Business GrowthTOKYO--(BUSINESS WIRE)--#ESG--Kao Corporation (TOKYO:4452), a Japan-based Group whose brand portfolio...

Celltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only omalizumab biosimilar approved in Europe

Omlyclo® (CT-P39), used to treat allergic asthma, chronic rhinosinusitis with nasal polyps (CRSwNP) and chronic spontaneous urticaria (CSU), becomes the first omalizumab biosimilar approved in the European Union The European Commission (EC) decision is based on clinical evidence, including results...

Worldcom Public Relations Group Expands Global Reach, Welcomes Two New Partners in Poland and South Korea

NEW YORK--(BUSINESS WIRE)--#worldcompr--The Worldcom Public Relations Group (Worldcom), the leading global partnership of independent public relations firms, announced today that it has welcomed two new partners to the organization. SAROTA PR in Krakow, Poland and Up & Company, Seoul,...

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395

Owkin has unveiled its pipeline of four early-stage de novo drug discovery programs and one patent-protected in-licensed drug asset, bringing its world-class data access and AI to the forefront of drug discovery and development Using its proprietary AI engines for...

ispace and University of Leicester Collaborate on Lunar Night Survival Technology

TOKYO--(BUSINESS WIRE)--ispace, inc. (ispace), a global lunar exploration company, and the University of Leicester, have agreed to collaborate on approaches to lunar night survivability for future ispace lunar lander and rover missions. The University and ispace have entered into a...

Syngenta Group and The Nature Conservancy (TNC) Extend Collaboration

Strengthening of a unique NGO-corporation collaboration model that links conservation goals with economic potential and addresses societal issues like deforestation and land degradation. Extension of multi-year agreement that started in 2018, focusing on five strategic projects across the globe. By 2026,...

Latest News

Eco Atlantic remains upbeat about stake in South America’s mega hotspot   

Eco (Atlantic) Oil & Gas Ltd. has reaffirmed its focus on Guyana, a key area for hydrocarbon exploration, where...